Prevention of postoperative nausea and vomiting (PONV)
Adult
5 mg IV single dose at induction
5 mg once
5 mg
Treatment of PONV
Adult
10 mg IV single dose
10 mg once
10 mg
Renal Undefined
Hepatic Undefined
Single-dose administration only.
Instructions
Infuse IV over 1–2 minutes; dilution not required.
Protect from light; administer within 12 hours of removing the vial from its carton.
Available strengths
inj 5 mg/2 mL
inj 10 mg/4 mL
Cautions
Dose- and concentration-dependent QT prolongation—avoid in congenital long QT syndrome and with droperidol; ECG monitoring with pre-existing arrhythmias/conduction disorders, electrolyte abnormalities, CHF, or other QT-prolonging drugs (e.g., ondansetron)
Adverse reactions
Increased blood prolactin
Chills
Hypokalemia
Procedural hypotension
Abdominal distension
Infusion site pain (treatment indication)
Pregnancy Insufficient human data; no adverse developmental effects in animal studies.
Lactation Present in human milk (11–20× plasma with chronic oral use); consider pumping and discarding milk for 48 h after a dose.
Cost
Amisulpride (SOLIAN)
Strength
#/mo
generic $/unit
CostPlus
5 mg/2 mL
inj
per unit
not offered
10 mg/4 mL
inj
per unit
not offered
NADAC is a voluntary CMS survey of what retail community pharmacies pay for the drugs they stock. Amisulpride is administered under clinical supervision and dispensed outside retail pharmacies, so it rarely appears on surveyed invoices.